Acute myeloid leukemia, disease (disorder)
AML 17 Clinical Trial Collection
Year Started: 2007
Samples from the AML 17 trial
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Clinical records | 3 - 6 months |
| Followup records | 3 - 6 months |
| Treatment records | 3 - 6 months |
Unknown
Young adult (18 - 40 years)
11 - 100 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Primary cells | Liquid nitrogen vapor phase | Not applicable | 26 - 50% | ||
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen vapor phase | Not applicable | 51 - 75% |
Unknown
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Primary cells | Liquid nitrogen vapor phase | Not applicable | 26 - 50% | ||
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen vapor phase | Not applicable | 75% -99% |
Unknown
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen vapor phase | Not applicable | 100% |